Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients
Journal of Immunology Research · 2024
DOI: 10.1155/2024/7112940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Ivette Orosa Vázquez und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center of Molecular Immunology, 15th Avenue and 216 Street, Siboney, Playa, Havana, Cuba. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Antibodies, Viral, Immunoglobulin G. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Understanding the immune response generated by SARS‐CoV‐2 is critical for assessing efficient therapeutic protocols and gaining insights into the durability of protective immunity. The current work was aimed at studying the specific humoral responses against SARS‐CoV‐2 in Cuban COVID‐19 convalescents. We developed suitable tools and methods based on ELISA methodology, for supporting this evaluation. Here, we describe the development of an ELISA for the quantification of anti‐RBD IgG titers in a large number of samples and a similar test in the presence of NH 4 SCN as chaotropic agent for estimating the RBD specific antibody avidity. Additionally, a simple and rapid ELISA based on antibody‐mediated blockage of the binding RBD‐ACE2 was implemented for detecting, as a surrogate of conventional test, the levels of anti‐RBD inhibitory antibodies in convalescent sera. In a cohort of 273 unvaccinated convalescents, we identified higher anti‐RBD IgG titer (1 : 1,330, p < 0.0001) and higher levels of inhibitory antibodies blocking RBD‐ACE2 binding (1 : 216, p < 0.05) among those who had recovered from severe illness. Our results suggest that disease severity, and not demographic features such as age, sex, and skin color, is the main determinant of the magnitude and neutralizing ability of the anti‐RBD antibody response. An additional paired longitudinal assessment in 14 symptomatic convalescents revealed a decline in the antiviral antibody response and the persistence of neutralizing antibodies for at least 4 months after the onset of symptoms. Overall, SARS‐CoV‐2 infection elicits different levels of antibody response according to disease severity that declines over time and can be monitored using our homemade serological assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center of Molecular Immunology, 15th Avenue and 216 Street, Siboney, Playa, Havana, Cuba.
- National Center of Medical Genetics, 31st Avenue, N°3102 and 146 Street, Cubanacán, Playa, Havana, Cuba.
- Julio Trigo Hospital, km 7½ Calzada de Bejucal, Diez de Octubre, Havana, Cuba.
- Research Center of Civil Defense, José de las Lajas, San, Mayabeque, Cuba.
- Centre for Immunoassays, 134st. And 25, Cubanacán, Playa, Havana, Cuba.
ORCID-Profile: Tania Carmenate
Zitieren
APA
Orosa Vázquez, I., Díaz, M., Zúñiga Rosales, Y., Amada, K., Chang, J., Relova Hernández, E., Tundidor, Y., Roblejo Balbuena, H., Monzón, G., Torres Rives, B., Noa Romero, E., Carrillo Valdés, D., Valdivia Álvarez, I., Delahanty Fernández, A., Díaz, C., Solozabal, J., Gil, M., Sánchez, B., Rojas, G., …, & Carmenate, T. (2024). Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients. Journal of Immunology Research. https://doi.org/10.1155/2024/7112940
Vancouver
Orosa Vázquez I, Díaz M, Zúñiga Rosales Y, Amada K, Chang J, Relova Hernández E, et al. Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients. Journal of Immunology Research. 2024. doi:10.1155/2024/7112940
BibTeX
@article{OrosaVzquez2024,
author = {Orosa Vázquez, Ivette and Díaz, Marianniz and Zúñiga Rosales, Yaima and Amada, Klayris and Chang, Janoi and Relova Hernández, Ernesto and Tundidor, Yaima and Roblejo Balbuena, Hilda and Monzón, Giselle and Torres Rives, Bárbara and Noa Romero, Enrique and Carrillo Valdés, Danay and Valdivia Álvarez, Irinia and Delahanty Fernández, Aurora and Díaz, Claudia and Solozabal, Joaquín and Gil, Mileidys and Sánchez, Belinda and Rojas, Gertrudis and Marcheco, Beatriz and Carmenate, Tania},
title = {Studying the Humoral Response against SARS‐CoV‐2 in Cuban COVID‐19 Recovered Patients},
journal = {Journal of Immunology Research},
year = {2024},
doi = {10.1155/2024/7112940}
}
EUVIMED